Vistagen to Present Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting - Yahoo Finance
Submitted by Anonymous (not verified) on Tue, 05/30/2023 - 20:15
